MedTrace Logo

Comparison Between a Telerehabilitation Program for Urinary Incontinence Versus a Conventional Face-to-face Program

NCT05114395 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2021-11-10

No results posted yet for this study

Summary

Urinary incontinence (UI) is defined as any involuntary loss of urine. It affects a significant percentage of the population, mainly female, with a prevalence of 21.4% in Portuguese women, having a negative impact on quality of life and sexual function.

About half presents with stress UI (SUI), followed by mixed UI (MUI), with isolated urgency UI being less common.

Pelvic floor rehabilitiation is a first line treatment for SUI and MUI, however, it is not yet defined which is the best treatment program or the ideal strategies to improve adherence to it.

Telerehabilitation assumed a leading role in the covid pandemic phase, although there are few studies on pelvic floor rehabilitation for UI, none in Portugal to date.

The authors aim to evaluate the effectiveness of a hybrid program of pelvic floor rehabilitation in female patients with SUI and MUI with a predominance of SUI, including consultation and face-to-face sessions complemented with telerehabilitation.

Conditions

  • Stress Urinary Incontinence
  • Incontinence, Urinary
  • Covid19
  • Pelvic Floor Muscle Weakness

Interventions

OTHER

Pelvic Floor Telerehabilitation Program

See experimental and active comparator arms.

OTHER

Pelvic Floor Face-to-Face Program

See experimental and active comparator arms.

Sponsors & Collaborators

  • Centro Hospitalar De São João, E.P.E.

    lead OTHER

Principal Investigators

  • Susana Moreira · Centro Hospitalar Universitário São João

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2021-07-12
Completion
2021-08-09

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05114395 on ClinicalTrials.gov